Back
06 Jan 2026
CEO of Salonpas maker seeks to take the US$2.9b drug firm private, Bloomberg reports
Summary
Hisamitsu Pharmaceutical Co., the Japanese maker of Salonpas pain-relief patches, is considering a buyout to privatize the company. The buyout, potentially worth JPY450 billion, is being led by CEO Kazuhide Nakatomi and financed by banks. This move aligns with a trend of Japanese companies exiting the public market to avoid regulatory pressures and focus on long-term strategies.